Method of treatment for obsessive-compulsive disorder
AssigneeThe Rockfeller University
InventorsMaria Karayiorgou, Joseph A. Gogos
Life of this patent
Estimating the term…
Abstract
Methods of identifying patients having a susceptibility to obsessive-compulsive disorder resultant from a reduced level of Catechol-O-methyltransferase (COMT) are described. Therapies, utilizing COMT or COMT agonists, or dopamine antagonists in combination therewith, are also envisioned, as well as methods for determining the patients which will benefit the most from such therapies.
Claims5
A method of detecting a susceptibility to, or the presence of, obsessive-compulsive disorder in Caucasian males which comprises:
- a) obtain a Catechol-O-methyltransferase (COMT)-containing sample from a Caucasian male;
- b) measure the level of COMT activity in said sample;
- and
- compare said level of enzymatic activity to a standard, whereby reduced enzymatic activity levels indicate the susceptibility to, or the presence of, obsessive-compulsive disorder in Caucasian males.
A method for detecting a susceptibility to, or the presence of, obsessive-compulsive disorder in Caucasian males wherein said method comprises:
- a) obtain a nucleic acid-containing sample from a Caucasian male;
- b) determine the presence, or absence, of a single base substitution at codon 158 of each allele of the COMT gene wherein a substitution of G to A in either, or both alleles, is indicative of a susceptibility to, or the presence of, obsessive-compulsive disorder in said Caucasian male.
A test kit to facilitate diagnosis and treatment of obsessive-compulsive disorder in Caucasian males, comprising:
- a) oligonucleotide primers of at least 15 nucleotides wherein said primers are fully complementary to the nucleotide residue sequence adjacent to codon 158 of the COMT gene;
- other reagents;
- and
- directions for use of said kit.
Dependencies are inferred from the claim text.